248. Glucose transporter type 1 deficiency
30 clinical trials, 9 drugs (DrugBank: 1 drug), 0 gene, 0 pathway
Searched query = "Glucose transporter type 1 deficiency", "GLUT1 deficiency"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04399954 (ClinicalTrials.gov) | February 24, 2020 | 18/5/2020 | Evaluation of Ketoflo | A Study to Evaluate the Acceptability of Ketoflo, a Food for Special Medical Purposes (FSMP) for Use in the Dietary Management of Epilepsy or Neurometabolic Conditions Requiring a Ketogenic Diet (KD) | Epilepsy Intractable;Glucose Transporter Type 1 Deficiency Syndrome;Ketogenic Dieting | Dietary Supplement: Ketoflo | Vitaflo International, Ltd | NULL | Recruiting | 3 Years | 18 Years | All | 15 | N/A | United Kingdom |